顺尔宁联合舒利迭气雾剂吸入治疗支气管哮喘的疗效观察

摘要

目的：观察顺尔宁联合舒利迭气雾剂吸入治疗支气管哮喘的治疗效果，分析其价值。方法我院抽取2012年1月至2013年11月到医院治疗的支气管哮喘52例患者，按照不同方法平均分成两组：一组是对照组，另一组是观察组，每组各26例患者。应用予布地奈德气雾剂吸入方法对对照组进行治疗；应用顺尔宁联合舒利迭气雾剂吸入对观察组进行治疗。结果观察组和对照组肺功能指标变化情况，观察组的MMEF、PEF以及FEV1明显高于对照组，两组数据都比差异明显，统计学有意义（P＜0.05）。应用ACT对两组治疗前后治疗效果进行评分，观察组经过治疗后由于对照组，两组数据都比差异明显，统计学有意义（P＜0.05）。结论临床中应用顺尔宁联合舒利迭气雾剂吸入治疗支气管哮喘获得满意的治疗效果，值得临床研究推广使用。%Objective To observe the Montelukast Combined with Seretide aerosol inhalation in treatment of bronchial asthma treatment effect, the analysis of its value.Methods In our hospital from January 2012 to November 2013 for treatment of 52 cases of bronchial asthma patients, according to the different methods are divided into two groups: one group is the control group, the other group is the observation group, each group had 26 patients. Application to Budesonide Aerosol inhalation treatment methods of the control group; the application of Singulair combined with Seretide in aerosol inhalation treatment on the observation group.Results The observation group and the control group lung function changes, the observation group MMEF, PEF and FEV1 were signiifcantly higher than those in control group, two groups of data are signiifcantly different, statistically signiifcant (P<0.05). Application of ACT in the two groups before and after treatment were observed, group after treatment as control group, two groups of data are signiifcantly different, statistically signiifcant (P<0.05).Conclusion The clinical application of Montelukast Combined with Seretide aerosol inhalation in treatment of bronchial asthma to obtain satisfactory curative effect, is worth the clinical research to promote.